Emerging opportunities for allosteric modulation of G-protein coupled receptors

Biochemical Pharmacology

Volumn 85, Issue 2, 2013, Pages 153-162

  Wang, Ching I Anderson ^a   Lewis, Richard J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Allosteric modulation; G protein coupled receptor; Oligomerisation; Orthosteric binding site; X ray crystallography

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

ALLOSTERISM; BINDING SITE; CELLULAR DISTRIBUTION; CRYSTAL STRUCTURE; LIGAND BINDING; MOLECULAR RECOGNITION; OLIGOMERIZATION; PRIORITY JOURNAL; REVIEW; X RAY CRYSTALLOGRAPHY;

EID: 84872024032     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.09.001     Document Type: Note

References (114)

1. S.R. George, B.F. O'Dowd, and S.P. Lee G-protein-coupled receptor oligomerization and its potential for drug discovery Nat Rev Drug Discov 1 2002 808 820
2. R.J. Lefkowitz, and S.K. Shenoy Transduction of receptor signals by beta-arrestins Science 308 2005 512 517
3. R. Fredriksson, and H.B. Schioth The repertoire of G-protein-coupled receptors in fully sequenced genomes Mol Pharmacol 67 2005 1414 1425
4. A. Wise, K. Gearing, and S. Rees Target validation of G-protein coupled receptors Drug Discov Today 7 2002 235 246
5. J. Ballesteros, and J. Ransom In-target versus off-target allosteric modulators of GPCRs Drug Discov Today: Ther Strateg 3 2006 445 450
6. P.J. Conn, A. Christopoulos, and C.W. Lindsley Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders Nat Rev Drug Discov 8 2009 41 54
7. G.A. Block, K.J. Martin, A.L. de Francisco, S.A. Turner, M.M. Avram, and M.G. Suranyi Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis N Engl J Med 350 2004 1516 1525
8. J.S. Lindberg, B. Culleton, G. Wong, M.F. Borah, R.V. Clark, and W.B. Shapiro Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study J Am Soc Nephrol 16 2005 800 807
9. A. Christopoulos Allosteric binding sites on cell-surface receptors: novel targets for drug discovery Nat Rev Drug Discov 1 2002 198 210
10. R. Fredriksson, M.C. Lagerstrom, L.G. Lundin, and H.B. Schioth The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol Pharmacol 63 2003 1256 1272
11. G. Milligan, and E. Kostenis Heterotrimeric G-proteins: a short history Br J Pharmacol 147 Suppl 1 2006 S46 S55
12. E. Hermans Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors Pharmacol Ther 99 2003 25 44
13. J. Ballesteros, and K. Palczewski G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin Curr Opin Drug Discov Devel 4 2001 561 574
14. L.M. Luttrell, and R.J. Lefkowitz The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals J Cell Sci 115 2002 455 465
15. J.F. Lopez-Gimenez, M. Canals, J.D. Pediani, and G. Milligan The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function Mol Pharmacol 71 2007 1015 1029
16. M. Mellado, J.M. Rodriguez-Frade, A.J. Vila-Coro, S. Fernandez, A. Martin de Ana, and D.R. Jones Chemokine receptor homo- or heterodimerization activates distinct signaling pathways EMBO J 20 2001 2497 2507
17. M. Rocheville, D.C. Lange, U. Kumar, R. Sasi, R.C. Patel, and Y.C. Patel Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers J Biol Chem 275 2000 7862 7869
18. S. Bulenger, S. Marullo, and M. Bouvier Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation Trends Pharmacol Sci 26 2005 131 137
19. D.A. Shapiro, K. Kristiansen, D.M. Weiner, W.K. Kroeze, and B.L. Roth Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6 J Biol Chem 277 2002 11441 11449
20. G.Y. Ng, B.F. O'Dowd, S.P. Lee, H.T. Chung, M.R. Brann, and P. Seeman Dopamine D2 receptor dimers and receptor-blocking peptides Biochem Biophys Res Commun 227 1996 200 204
21. P. Hernanz-Falcon, J.M. Rodriguez-Frade, A. Serrano, D. Juan, A. del Sol, and S.F. Soriano Identification of amino acid residues crucial for chemokine receptor dimerization Nat Immunol 5 2004 216 223
22. K.A. Jones, B. Borowsky, J.A. Tamm, D.A. Craig, M.M. Durkin, and M. Dai GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2 Nature 396 1998 674 679
23. J.H. White, A. Wise, M.J. Main, A. Green, N.J. Fraser, and G.H. Disney Heterodimerization is required for the formation of a functional GABA(B) receptor Nature 396 1998 679 682
24. K. Kaupmann, B. Malitschek, V. Schuler, J. Heid, W. Froestl, and P. Beck GABA(B)-receptor subtypes assemble into functional heteromeric complexes Nature 396 1998 683 687
25. R. Kuner, G. Kohr, S. Grunewald, G. Eisenhardt, A. Bach, and H.C. Kornau Role of heteromer formation in GABAB receptor function Science 283 1999 74 77
26. I. Gomes, B.A. Jordan, A. Gupta, N. Trapaidze, V. Nagy, and L.A. Devi Heterodimerization of mu and delta opioid receptors: a role in opiate synergy J Neurosci 20 2000 RC110
27. B.A. Jordan, and L.A. Devi G-protein-coupled receptor heterodimerization modulates receptor function Nature 399 1999 697 700
28. M. Rocheville, D.C. Lange, U. Kumar, S.C. Patel, R.C. Patel, and Y.C. Patel Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity Science 288 2000 154 157
29. A.J. Pace, L. Gama, and G.E. Breitwieser Dimerization of the calcium-sensing receptor occurs within the extracellular domain and is eliminated by Cys - > Ser mutations at Cys101 and Cys236 J Biol Chem 274 1999 11629 11634
30. K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, H. Motoshima, and B.A. Fox Crystal structure of rhodopsin: a G protein-coupled receptor Science 289 2000 739 745
31. P. Argos, J.K. Rao, and P.A. Hargrave Structural prediction of membrane-bound proteins Eur J Biochem 128 1982 565 575
32. M. Congreve, S.P. Andrews, A.S. Dore, K. Hollenstein, E. Hurrell, and C.J. Langmead Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design J Med Chem 55 2012 1898 1903
33. A.S. Dore, N. Robertson, J.C. Errey, I. Ng, K. Hollenstein, and B. Tehan Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine Structure 19 2011 1283 1293
34. G. Lebon, T. Warne, P.C. Edwards, K. Bennett, C.J. Langmead, and A.G. Leslie Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation Nature 474 2011 521 525
35. T. Warne, M.J. Serrano-Vega, J.G. Baker, R. Moukhametzianov, P.C. Edwards, and R. Henderson Structure of a beta1-adrenergic G-protein-coupled receptor Nature 454 2008 486 491
36. D.M. Rosenbaum, C. Zhang, J.A. Lyons, R. Holl, D. Aragao, and D.H. Arlow Structure and function of an irreversible agonist-beta(2) adrenoceptor complex Nature 469 2011 236 240
37. E.Y. Chien, W. Liu, Q. Zhao, V. Katritch, G.W. Han, and M.A. Hanson Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist Science 330 2010 1091 1095
38. V.P. Jaakola, M.T. Griffith, M.A. Hanson, V. Cherezov, E.Y. Chien, and J.R. Lane The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist Science 322 2008 1211 1217
39. V. Cherezov, D.M. Rosenbaum, M.A. Hanson, S.G. Rasmussen, F.S. Thian, and T.S. Kobilka High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor Science 318 2007 1258 1265
40. F. Xu, H. Wu, V. Katritch, G.W. Han, K.A. Jacobson, and Z.G. Gao Structure of an agonist-bound human A2A adenosine receptor Science 332 2011 322 327
41. T. Shimamura, M. Shiroishi, S. Weyand, H. Tsujimoto, G. Winter, and V. Katritch Structure of the human histamine H1 receptor complex with doxepin Nature 475 2011 65 70
42. M.A. Hanson, C.B. Roth, E. Jo, M.T. Griffith, F.L. Scott, and G. Reinhart Crystal structure of a lipid G protein-coupled receptor Science 335 2012 851 855
43. B. Wu, E.Y. Chien, C.D. Mol, G. Fenalti, W. Liu, and V. Katritch Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 330 2010 1066 1071
44. A.C. Kruse, J. Hu, A.C. Pan, D.H. Arlow, D.M. Rosenbaum, and E. Rosemond Structure and dynamics of the M3 muscarinic acetylcholine receptor Nature 482 2012 552 556
45. K. Haga, A.C. Kruse, H. Asada, T. Yurugi-Kobayashi, M. Shiroishi, and C. Zhang Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist Nature 482 2012 547 551
46. S.G. Rasmussen, H.J. Choi, J.J. Fung, E. Pardon, P. Casarosa, and P.S. Chae Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor Nature 469 2011 175 180
47. S.G. Rasmussen, B.T. DeVree, Y. Zou, A.C. Kruse, K.Y. Chung, and T.S. Kobilka Crystal structure of the beta2 adrenergic receptor-Gs protein complex Nature 477 2011 549 555
48. S.G. Rasmussen, H.J. Choi, D.M. Rosenbaum, T.S. Kobilka, F.S. Thian, and P.C. Edwards Crystal structure of the human beta2 adrenergic G-protein-coupled receptor Nature 450 2007 383 387
49. R. Nygaard, T.M. Frimurer, B. Holst, M.M. Rosenkilde, and T.W. Schwartz Ligand binding and micro-switches in 7TM receptor structures Trends Pharmacol Sci 30 2009 249 259
50. E.H. Schneider, D. Schnell, A. Strasser, S. Dove, and R. Seifert Impact of the DRY motif and the missing "ionic lock" on constitutive activity and G-protein coupling of the human histamine H4 receptor J Pharmacol Exp Ther 333 2010 382 392
51. A.E. Alewijnse, H. Timmerman, E.H. Jacobs, M.J. Smit, E. Roovers, and S. Cotecchia The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor Mol Pharmacol 57 2000 890 898
52. T.D. Romo, A. Grossfield, and M.C. Pitman Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics Biophys J 98 2010 76 84
53. F. Fanelli, and A. Felline Dimerization and ligand binding affect the structure network of A(2A) adenosine receptor Biochim Biophys Acta 1808 2011 1256 1266
54. J.S. Mills, H.M. Miettinen, D. Cummings, and A.J. Jesaitis Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu J Biol Chem 275 2000 39012 39017
55. L. Shi, G. Liapakis, R. Xu, F. Guarnieri, J.A. Ballesteros, and J.A. Javitch Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch J Biol Chem 277 2002 40989 40996
56. E. Crocker, M. Eilers, S. Ahuja, V. Hornak, A. Hirshfeld, and M. Sheves Location of Trp265 in metarhodopsin II: implications for the activation mechanism of the visual receptor rhodopsin J Mol Biol 357 2006 163 172
57. C.E. Elling, T.M. Frimurer, L.O. Gerlach, R. Jorgensen, B. Holst, and T.W. Schwartz Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation J Biol Chem 281 2006 17337 17346
58. D.L. Farrens, C. Altenbach, K. Yang, W.L. Hubbell, and H.G. Khorana Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin Science 274 1996 768 770
59. P. Ghanouni, J.J. Steenhuis, D.L. Farrens, and B.K. Kobilka Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor Proc Natl Acad Sci U S A 98 2001 5997 6002
60. J.A. Javitch, D. Fu, G. Liapakis, and J. Chen Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment J Biol Chem 272 1997 18546 18549
61. A.D. Jensen, F. Guarnieri, S.G. Rasmussen, F. Asmar, J.A. Ballesteros, and U. Gether Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling J Biol Chem 276 2001 9279 9290
62. S.W. Lin, and T.P. Sakmar Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state Biochemistry 35 1996 11149 11159
63. T.E. Angel, M.R. Chance, and K. Palczewski Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors Proc Natl Acad Sci U S A 106 2009 8555 8560
64. T.E. Angel, S. Gupta, B. Jastrzebska, K. Palczewski, and M.R. Chance Structural waters define a functional channel mediating activation of the GPCR, rhodopsin Proc Natl Acad Sci U S A 106 2009 14367 14372
65. T. Orban, S. Gupta, K. Palczewski, and M.R. Chance Visualizing water molecules in transmembrane proteins using radiolytic labeling methods Biochemistry 49 2010 827 834
66. L. Pardo, X. Deupi, N. Dolker, M.L. Lopez-Rodriguez, and M. Campillo The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors ChemBioChem 8 2007 19 24
67. M.A. Hanson, V. Cherezov, M.T. Griffith, C.B. Roth, V.P. Jaakola, and E.Y. Chien A specific cholesterol binding site is established by the 2.8 structure of the human beta2-adrenergic receptor Structure 16 2008 897 905
68. D. Wacker, G. Fenalti, M.A. Brown, V. Katritch, R. Abagyan, and V. Cherezov Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography J Am Chem Soc 132 2010 11443 11445
69. T. Warne, R. Moukhametzianov, J.G. Baker, R. Nehme, P.C. Edwards, and A.G. Leslie The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor Nature 469 2011 241 244
70. S.S. Karnik, and H.G. Khorana Assembly of functional rhodopsin requires a disulfide bond between cysteine residues 110 and 187 J Biol Chem 265 1990 17520 17524
71. S.S. Karnik, T.P. Sakmar, H.B. Chen, and H.G. Khorana Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin Proc Natl Acad Sci U S A 85 1988 8459 8463
72. H. Zhou, and H.H. Tai Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding Arch Biochem Biophys 373 2000 211 217
73. C.M. Fraser Site-directed mutagenesis of beta-adrenergic receptors. Identification of conserved cysteine residues that independently affect ligand binding and receptor activation J Biol Chem 264 1989 9266 9270
74. H.G. Dohlman, M.G. Caron, A. DeBlasi, T. Frielle, and R.J. Lefkowitz Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor Biochemistry 29 1990 2335 2342
75. S. Lin, U. Gether, and B.K. Kobilka Ligand stabilization of the beta 2 adrenergic receptor: effect of DTT on receptor conformation monitored by circular dichroism and fluorescence spectroscopy Biochemistry 35 1996 14445 14451
76. E. Kurtenbach, C.A. Curtis, E.K. Pedder, A. Aitken, A.C. Harris, and E.C. Hulme Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation J Biol Chem 265 1990 13702 13708
77. J.V. Cook, and K.A. Eidne An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation Endocrinology 138 1997 2800 2806
78. J.H. Perlman, W. Wang, D.R. Nussenzveig, and M.C. Gershengorn A disulfide bond between conserved extracellular cysteines in the thyrotropin-releasing hormone receptor is critical for binding J Biol Chem 270 1995 24682 24685
79. J.A. Salon, D.T. Lodowski, and K. Palczewski The significance of G protein-coupled receptor crystallography for drug discovery Pharmacol Rev 63 2011 901 937
80. S.A. Correa, G.C. Pignatari, E.S. Ferro, N.A. Pacheco, C.M. Costa-Neto, and J.B. Pesquero Role of the Cys18-Cys274 disulfide bond and of the third extracellular loop in the constitutive activation and internalization of angiotensin II type 1 receptor Regul Pept 134 2006 132 140
81. D.M. Rosenbaum, V. Cherezov, M.A. Hanson, S.G. Rasmussen, F.S. Thian, and T.S. Kobilka GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function Science 318 2007 1266 1273
82. M.P. Bokoch, Y. Zou, S.G. Rasmussen, C.W. Liu, R. Nygaard, and D.M. Rosenbaum Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor Nature 463 2010 108 112
83. S.F. Altschul, W. Gish, W. Miller, E.W. Myers, and D.J. Lipman Basic local alignment search tool J Mol Biol 215 1990 403 410
84. S.F. Altschul, T.L. Madden, A.A. Schaffer, J.H. Zhang, Z. Zhang, and W. Miller Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res 25 1997 3389 3402
85. W. Liu, E. Chun, A.A. Thompson, P. Chubukov, F. Xu, and V. Katritch Structural basis for allosteric regulation of GPCRs by sodium ions Science 337 2012 232 236
86. P. Keov, P.M. Sexton, and A. Christopoulos Allosteric modulation of G protein-coupled receptors: a pharmacological perspective Neuropharmacology 60 2011 24 35
87. J.E. Marlo, C.M. Niswender, E.L. Days, T.M. Bridges, Y. Xiang, and A.L. Rodriguez Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity Mol Pharmacol 75 2009 577 588
88. C.K. Jones, A.E. Brady, A.A. Davis, Z. Xiang, M. Bubser, and M.N. Tantawy Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats J Neurosci 28 2008 10422 10433
89. S. Lazareno, V. Dolezal, A. Popham, and N.J. Birdsall Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity Mol Pharmacol 65 2004 257 266
90. I. Kufareva, M. Rueda, V. Katritch, R.C. Stevens, and R. Abagyan Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment Structure 19 2011 1108 1126
91. M. Michino, E. Abola, C.L. Brooks 3rd, J.S. Dixon, J. Moult, and R.C. Stevens Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 Nat Rev Drug Discov 8 2009 455 463
92. L. Skrabanek, M. Murcia, M. Bouvier, L. Devi, S.R. George, and M.J. Lohse Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base BMC Bioinformatics 8 2007 177
93. G. Khelashvili, K. Dorff, J. Shan, M. Camacho-Artacho, L. Skrabanek, and B. Vroling GPCR-OKB: the G protein coupled receptor oligomer knowledge base Bioinformatics 26 2010 1804 1805
94. G. Milligan G protein-coupled receptor dimerisation: molecular basis and relevance to function Biochim Biophys Acta 1768 2007 825 835
95. I. Gomes, A. Gupta, J. Filipovska, H.H. Szeto, J.E. Pintar, and L.A. Devi A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia Proc Natl Acad Sci U S A 101 2004 5135 5139
96. J.R. Traynor, and J. Elliott delta-Opioid receptor subtypes and cross-talk with mu-receptors Trends Pharmacol Sci 14 1993 84 86
97. C. Lavoie, J.F. Mercier, A. Salahpour, D. Umapathy, A. Breit, and L.R. Villeneuve Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy J Biol Chem 277 2002 35402 35410
98. C. Lavoie, and T.E. Hebert Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers Can J Physiol Pharmacol 81 2003 186 195
99. J.F. Mercier, A. Salahpour, S. Angers, A. Breit, and M. Bouvier Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer J Biol Chem 277 2002 44925 44931
100. A. Breit, M. Lagace, and M. Bouvier Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties J Biol Chem 279 2004 28756 28765
101. L. Barki-Harrington, L.M. Luttrell, and H.A. Rockman Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo Circulation 108 2003 1611 1618
102. M.A. Uberti, C. Hague, H. Oller, K.P. Minneman, and R.A. Hall Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors J Pharmacol Exp Ther 313 2005 16 23
103. J. Xu, J. He, A.M. Castleberry, S. Balasubramanian, A.G. Lau, and R.A. Hall Heterodimerization of alpha 2A- and beta 1-adrenergic receptors J Biol Chem 278 2003 10770 10777
104. J.J. Carrillo, J. Pediani, and G. Milligan Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins J Biol Chem 278 2003 42578 42587
105. M.A. Uberti, R.A. Hall, and K.P. Minneman Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties Mol Pharmacol 64 2003 1379 1390
106. C. Hague, M.A. Uberti, Z. Chen, R.A. Hall, and K.P. Minneman Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors J Biol Chem 279 2004 15541 15549
107. L. Stanasila, J.B. Perez, H. Vogel, and S. Cotecchia Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization J Biol Chem 278 2003 40239 40251
108. C. Smith, and M. Teitler Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors Cardiovasc Drugs Ther 13 1999 123 126
109. J.G. Baker The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors Br J Pharmacol 144 2005 317 322
110. I. Sela, G. Golan, M. Strajbl, D. Rivenzon-Segal, S. Bar-Haim, and I. Bloch G protein coupled receptors -in silico drug discovery and design Curr Top Med Chem 10 2010 638 656
111. M. Sabio, K. Jones, and S. Topiol Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: identification of active compounds Bioorg Med Chem Lett 18 2008 5391 5395
112. P. Kolb, D.M. Rosenbaum, J.J. Irwin, J.J. Fung, B.K. Kobilka, and B.K. Shoichet Structure-based discovery of beta2-adrenergic receptor ligands Proc Natl Acad Sci U S A 106 2009 6843 6848
113. V. Katritch, V.P. Jaakola, J.R. Lane, J. Lin, A.P. Ijzerman, and M. Yeager Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists J Med Chem 53 2010 1799 1809
114. J. Carlsson, L. Yoo, Z.G. Gao, J.J. Irwin, B.K. Shoichet, and K.A. Jacobson Structure-based discovery of A2A adenosine receptor ligands J Med Chem 53 2010 3748 3755